X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Insights

New Zenytime “Puck” Is First Bluetooth Device That Allows Users to Play Games and Reduce Stress Using Only Their Breath

Yuvraj_pawp by Yuvraj_pawp
4th September 2014
in Insights

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Now available for pre-order, unique patented sensor allows Zenytime users to practice conscious breathing while playing games on their smartphone or tablet.

 

Zenytime, a technology company on a mission to help people reduce stress and feel better using their breath, today announced its pre-ordering campaign to introduce its first consumer product, a wellness connected device that turns breathing into game controls. The games coaches users to do healthful breathing exercises on their smartphones or tablets.

 

Zenytime is the first device designed to help users improve their well-being by playing mobile games using only their breath. Mixing self-improvement and gamification, it promotes serenity, clarity and energy for busy minds and bodies in just a few breaks a day. It is not a wearable device but rather a small companion that fits in pocket, purse, bag, keychain or any carry-on.

 

The Zenytime solution enables gaming apps to act as breathing coaches thanks to a Bluetooth accessory called “the Puck” which features an exclusive patented sensor that tracks controlled breathing and translates it into game controls. To deliver a comprehensive experience, the Puck also captures heart rate and blood oxygen levels. It integrates Bluetooth 4.0 for long battery life and seamless connection with iOS and Android mobile platforms.

 

Zenytime games are founded on scientifically proven breathing patterns for improving stress management, cardiovascular health and cognitive and athletic performance. The Zenytime dashboard provides stats, tips and rewards toward a healthier you.

 

“Our games have been designed to promote deep, rhythmic breathing to bring more oxygen into your cells and to trigger the many short-term rewards of controlled breathing,” said co-founder Celine Vignal. “Zenytime games are adapted to people of any age, as well as exercise enthusiasts and professional athletes.”

 

The Zenytime team is helped by highly qualified advisors, including Dr. Melissa Conrad Stöppler, recipient of a Physician Scientist Award from the U.S. National Cancer Institute; Dr. Jim Taylor, an internationally-recognized authority on the psychology of performance in business and sport; and Ultramarathon Man Dean Karnazes, named one of the “Top 100 Most Influential People in the World” by TIME magazine.

 

Zenytime is currently developing games with key players in complementary industries such as yoga, fitness, sports and wellness. Designed to respond to specific interests, branded games will mix partners’ expertise and Zenytime’s competencies, and will be available for free to all Zenytime users.

 

Zenytime is priced at $99 but is available at $79 during the pre-order period with free shipping in the US and Canada. Shipping expected in the winter, 2014/2015.

SOURCE Zenytime

Previous Post

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

Next Post

Bayer seeks marketing authorisation of aflibercept solution for injection in Japan

Related Posts

wearable drug delivery devices
Insights

Wearable Drug Delivery Devices for On-Demand Care

27th September 2025
high volume injectable formulations
Insights

Overcoming Challenges in High-Volume Injectable Formulations

27th September 2025
Insights

Smart Drug Delivery Systems for Patient Care

27th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
active pharmaceutical ingredients supply chain
Drug Development

Future of Active Pharmaceutical Ingredients Supply

26th September 2025
pharmaceutical excipients for new therapies
Drug Development

Advances in Pharmaceutical Excipients for New Therapies

26th September 2025
Next Post

Pharmacy Creations Issues- Limited Distribution In Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In